Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hantaan virus glycoprotein C (Gc) is a critical structural protein of the Hantaan virus (HTNV), the prototype member of the Orthohantavirus genus and the primary cause of Hemorrhagic Fever with Renal Syndrome (HFRS) (UniProt: P08668; PubMed: 30626688). Gc functions as a class II viral fusion protein, working in a heterodimeric complex with glycoprotein Gn to facilitate viral attachment and entry into host cells (PubMed: 27851987). Following receptor-mediated endocytosis, the low pH environment of the endosome triggers a dramatic conformational change in Gc, leading to the fusion of the viral envelope with the endosomal membrane (PubMed: 31142630). As the major target for neutralizing antibodies, Gc is the focus of vaccine strategies and the development of therapeutic monoclonal antibodies, such as ADI-42898, which aim to block the fusion loop or prevent the transition from a pre-fusion to a post-fusion state (PubMed: 33408178). Understanding the structural biology of Gc is essential for designing broad-spectrum therapeutics against various hantaviruses that pose significant public health threats (Wikipedia: Hantaan virus). Current research emphasizes the identification of conserved epitopes on Gc to develop treatments that are effective across multiple hantavirus species (NIH: Hantavirus entry mechanisms).
Neutralization of viral entry by blocking membrane fusion or receptor binding (PubMed: 33408178, 31142630).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hantaan virus glycoprotein C (Gc) (HTNV Gc).